Labeler
Fresenius Kabi USA, LLC NDC Codes
Fresenius Kabi USA, LLC lists 562 finished drug products in the FDA NDC Directory under NDC labeler codes 63323, 65219, 76045.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tyenne, Rocuronium, Sodium chloride, Dextrose, Otulfi, Nicardipine Hydrochloride, Sterile Water, Levetiracetam, Cyclophosphamide, Vitalipid N, ketamine hydrochloride, Ustekinumab-Aauz, Sodium Bicarbonate, ephedrine sulfate, Bomyntra
- Active ingredients
- Tocilizumab, Ustekinumab, Rocuronium bromide, Sodium chloride, Dextrose monohydrate, Phytonadione, Nicardipine hydrochloride, Water, Levetiracetam, Denosumab, Cyclophosphamide, Vitamin a palmitate
- NDC labeler codes
- 63323, 65219, 76045
- Strengths (from the 100 most recently listed products)
- Rocuronium bromide 10 mg/mL; Dextrose monohydrate 50 mg/mL; Tocilizumab 162 mg/.9mL; Water 1 mL/mL; Sodium chloride .9 g/100mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Ephedrine sulfate 5 mg/mL; Denosumab 70 mg/mL; Succinylcholine chloride dihydrate 20 mg/mL; Diphenhydramine hydrochloride 50 mg/mL; Amiodarone hydrochloride 50 mg/mL; Epinephrine 1 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Acyclovir sodium 50 mg/mL; Gadobutrol 604.72 mg/mL; Desmopressin acetate 4 ug/mL; Vitamin a palmitate 230 [iU]/mL; Ergocalciferol 40 [iU]/mL; .alpha.-tocopherol, Dl- .7 [iU]/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Solution, Concentrate, Kit, Injection, Powder, For solution, Emulsion, Injection, Emulsion, Injection, Powder, Lyophilized, For solution, Solution
- Routes
- Intravenous, Subcutaneous, Intramuscular, Irrigation, Oral, Epidural, Infiltration, Perineural, Intraocular
- Drug classes (FDA established)
- Osmotic Laxative, Interleukin-6 Receptor Antagonist, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Potassium Salt, Nondepolarizing Neuromuscular Blocker, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, Dihydropyridine Calcium Channel Blocker, RANK Ligand Inhibitor, Provitamin D2 Compound, Vitamin A, General Anesthetic, Norepinephrine Releasing Agent, Depolarizing Neuromuscular Blocker, Histamine-1 Receptor Antagonist, Antiarrhythmic, Catecholamine, Phenothiazine, Benzodiazepine, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Opioid Antagonist, Gadolinium-based Contrast Agent, Factor VIII Activator, Vasopressin Analog, alpha-1 Adrenergic Agonist, Vitamin C, Paramagnetic Contrast Agent, Lipoglycopeptide Antibacterial, Heparin Reversal Agent, beta-Adrenergic Blocker, Amide Local Anesthetic, Calcitonin, Antifibrinolytic Agent, Calcium Channel Blocker, Proton Pump Inhibitor, Oxytocic, Corticosteroid, Anticholinergic, Hematopoietic Stem Cell Mobilizer
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Midazolammidazolam hydrochloride | Midazolam hydrochloride 2 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-001 | 76045-0001-20 | — |
| Midazolammidazolam hydrochloride | Midazolam hydrochloride 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-002 | 76045-0002-10 | — |
| Midazolammidazolam hydrochloride | Midazolam hydrochloride 10 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-003 | — | — |
| Zoledronic Acid | Zoledronic acid 4 mg/5mL | InjectionIntravenous | 63323-961 | 63323-0961-98 | — |
| Kabivendextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine | Dextrose monohydrate 10.8 g/100mL + 23 more ingredients | Injection, EmulsionIntravenous | 63323-712 | 63323-0712-1063323-0712-1563323-0712-20+1 more | — |
| Perikabivendextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine | Dextrose monohydrate 7.5 g/100mL + 23 more ingredients | Injection, EmulsionIntravenous | 63323-714 | 63323-0714-1463323-0714-19 | — |
| Rifampin | Rifampin 600 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-351 | 63323-0351-20 | — |
| Acetylcysteine | Acetylcysteine 100 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-691 | 63323-0691-30 | — |
| Acetylcysteine | Acetylcysteine 100 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-693 | 63323-0693-10 | — |
| Acetylcysteine | Acetylcysteine 100 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-695 | 63323-0695-04 | — |
| Morphine Sulfate | Morphine sulfate 2 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-004 | 76045-0004-11 | — |
| Morphine Sulfate | Morphine sulfate 4 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-005 | 76045-0005-11 | — |
| Morphine Sulfate | Morphine sulfate 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-006 | — | — |
| Morphine Sulfate | Morphine sulfate 8 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-007 | — | — |
| Morphine Sulfate | Morphine sulfate 10 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-008 | — | — |
| Morphine Sulfate | Morphine sulfate 1 mg/.5mL | Injection, SolutionIntramuscular, Intravenous | 76045-238 | 76045-0238-10 | — |
| Levofloxacin | Levofloxacin 5 mg/mL | InjectionIntravenous | 63323-355 | 63323-0355-5063323-0355-6063323-0355-65 | — |
| Metoclopramidemetoclopramide hydrochloride | Metoclopramide hydrochloride 10 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-101 | 76045-0101-20 | — |
| Metoclopramidemetoclopramide hydrochloride | Metoclopramide hydrochloride 10 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-213 | 76045-0213-20 | — |
| Diphenhydramine Hydrochloride | Diphenhydramine hydrochloride 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | 76045-102 | 76045-0102-10 | — |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | 63323-963 | 63323-0963-44 | — |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-690 | 63323-0690-30 | — |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-692 | 63323-0692-10 | — |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionOral, Respiratory (Inhalation) | 63323-694 | 63323-0694-44 | — |
| Imipenem and Cilastatinimipenem and cilastatin sodium | Imipenem 500 mg/20mL; Cilastatin sodium 500 mg/20mL | Injection, Powder, For solutionIntravenous | 63323-322 | 63323-0322-25 | — |
| Imipenem and Cilastatinimipenem and cilastatin sodium | Imipenem 250 mg/20mL; Cilastatin sodium 250 mg/20mL | Injection, Powder, For solutionIntravenous | 63323-349 | 63323-0349-94 | — |
| Meropenem | Meropenem 1 g/20mL | Injection, Powder, For solutionIntravenous | 63323-508 | 63323-0508-31 | — |
| Meropenem | Meropenem 500 mg/10mL | Injection, Powder, For solutionIntravenous | 63323-507 | 63323-0507-20 | — |
| Gemcitabine | Gemcitabine hydrochloride 200 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-102 | 63323-0102-94 | — |
| Gemcitabine | Gemcitabine hydrochloride 1 g/25mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-125 | 63323-0125-53 | — |
| Gemcitabine | Gemcitabine hydrochloride 2 g/50mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-126 | 63323-0126-03 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 15 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-493 | 63323-0493-9163323-0493-97 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-496 | 63323-0496-97 | — |
| Cefazolincefazolin sodium | Cefazolin sodium 500 mg/2.2mL | Powder, For solutionIntramuscular, Intravenous | 63323-236 | 63323-0236-10 | — |
| Cefazolincefazolin sodium | Cefazolin sodium 1 g/3mL | Powder, For solutionIntramuscular, Intravenous | 63323-237 | 63323-0237-10 | — |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 1 g/1 | Powder, For solutionIntravenous | 63323-341 | 63323-0341-25 | — |
| Cefoxitincefoxitin sodium | Cefoxitin sodium 2 g/1 | Powder, For solutionIntravenous | 63323-342 | 63323-0342-29 | — |
| Nafcillinnafcillin sodium | Nafcillin sodium 1 g/4mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-327 | 63323-0327-10 | — |
| Nafcillinnafcillin sodium | Nafcillin sodium 2 g/8mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-328 | 63323-0328-20 | — |
| Levothyroxine Sodiumlevothyroxine sodium anhydrous | Levothyroxine sodium anhydrous 200 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-647 | 63323-0647-10 | — |
| Levothyroxine Sodiumlevothyroxine sodium anhydrous | Levothyroxine sodium anhydrous 500 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-648 | 63323-0648-10 | — |
| Levothyroxine Sodiumlevothyroxine sodium anhydrous | Levothyroxine sodium anhydrous 100 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-649 | 63323-0649-94 | — |
| Ceftriaxone | Ceftriaxone sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 63323-346 | 63323-0346-10 | J0696 |
| Cefazolincefazolin sodium | Cefazolin sodium 10 g/1 | Powder, For solutionIntravenous | 63323-238 | 63323-0238-61 | — |
| Piperacillin and Tazobactampiperacillin sodium and tazobactam sodium | Piperacillin sodium 36 g/180mL; Tazobactam sodium 4.5 g/180mL | Injection, Powder, For solutionIntravenous | 63323-304 | 63323-0304-94 | — |
| Benztropine Mesylate | Benztropine mesylate 1 mg/mL | Injection, SolutionIntramuscular, Intravenous | 63323-970 | 63323-0970-02 | — |
| Nafcillin | Nafcillin sodium 10 g/100mL | Injection, Powder, For solutionIntravenous | 63323-330 | 63323-0330-60 | — |
| Chorionic Gonadotropin | — | Kit | 63323-030 | 63323-0030-11 | — |
| Sumatriptan Succinate | Sumatriptan succinate 6 mg/.5mL | InjectionSubcutaneous | 63323-273 | 63323-0273-01 | — |
| Terbutaline Sulfate | Terbutaline sulfate 1 mg/mL | Injection, SolutionSubcutaneous | 63323-665 | 63323-0665-01 | — |
Fresenius Kabi USA, LLC: common questions
- What is Fresenius Kabi USA, LLC's NDC labeler code?
- 63323, 65219, 76045. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Fresenius Kabi USA, LLC?
- Med-Code's HCPCS directory matches J3357, J0897, J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.